Concepedia

Clifford R. Restaino

CR

4

Publications

1.1K

Citations

4

H-Index

2007

Active since

Affiliations

Massachusetts General Hospital(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Harvard University

Massachusetts Institute of Technology

Clifford R. Restaino is an author at Massachusetts General Hospital specializing in drug discovery, medicine, and tumor biology.

Top concepts

Publications per year

2007–2016

4

Publications

4

Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

Erick J. Morris, Sharda Jha, Clifford R. Restaino et al. · Cancer Discovery · 2013 · 673 citations · Full text

, , +20

Mast cells are an essential hematopoietic component for polyp development

Elias Gounaris, Susan E. Erdman, Clifford R. Restaino et al. · Proceedings of the National Academy of Sciences · 2007 · 249 citations · Full text

Live Imaging of Cysteine-Cathepsin Activity Reveals Dynamics of Focal Inflammation, Angiogenesis, and Polyp Growth

Elias Gounaris, Ching‐Hsuan Tung, Clifford R. Restaino et al. · PLoS ONE · 2008 · 109 citations · Full text

Dissecting Therapeutic Resistance to ERK Inhibition

Sharda Jha, Erick J. Morris, Alan Hruza et al. · Molecular Cancer Therapeutics · 2016 · 52 citations · Full text

, , +15

Rows per page

1–4 of 4